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Abstract: Background: Different anesthetic protocols may influence endobronchial ultrasound-guided
needle aspiration (EBUS-TBNA) outcomes, patient comfort, and even safety. In this study, two anesthesia
techniques were assessed and compared for EBUS-TBNA. Methods: A prospective, multicenter study
was carried out. Patients were allocated to Group 1 (general anesthesia with neuromuscular blockade
and controlled ventilation) and Group 2 (intravenous sedation). EBUS-TBNA accuracy was the primary
outcome. Safety, patient comfort and satisfaction, and operators’ difficulties were defined as secondary
outcomes. Results: Of the 115 patients enrolled (Group 1 = 59, Group 2 = 56), EBUS-TBNA was
performed for hilar or mediastinal lesion diagnosis and lung cancer staging in, respectively, 77 (67%)
and 38 (33%) patients. The numbers of lymph nodes stations (1.8 ± 1.0 vs. 1.7 ± 1.0, p = 0.472) and
punctures per station (6.9 ± 3.1 vs. 6.0 ± 2.5, p = 0.084) were similar between groups. Adequate
samples were obtained from 109 patients (97.3%) with similar diagnostic accuracy. Procedure duration
was not significantly different (p = 0.348). Hemodynamic parameters and systolic and diastolic blood
pressures were higher in Group 1 at the beginning and at the end of the procedure. Adverse events
were equally distributed, and no significant differences were found regarding patient satisfaction and
bronchoscopist/anesthesiologist difficulties. Conclusions: The type of anesthesia used did not influence
EBUS-TBNA outcomes. EBUS-TBNA performed under sedation or general anesthesia did not affect the
diagnostic yield, complication rate, and patients’ comfort and satisfaction.
Keywords: endobronchial ultrasound; general anesthesia; sedation; diagnosis; staging
1. Introduction
Endobronchial ultrasound-guided needle aspiration (EBUS-TBNA) is useful in the diagnosis of
a wide range of clinical situations, besides being considered the first-choice method for mediastinal
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staging of lung cancer due to its high yield, low rate of complications, and reduced costs [1,2].
For optimal performance, it is desirable to have a collaborative patient; the procedure induces cough,
increases airway secretions, and reduces airway caliber. Furthermore, during the EBUS-TBNA staging
procedure, all relevant lymph node stations should be evaluated and punctured at least three times,
resulting in increased procedure length and patient discomfort [3,4].
The type of sedation used during EBUS-TBNA is also extremely important, because it can affect
the diagnostic accuracy, procedure safety, and patient comfort, and at same time determines the need
for additional health-care resources and increased care costs. A guideline and panel report of experts
suggest that moderate or deep sedation are acceptable approaches during EBUS-TBNA [5], but the poor
quality of the published studies has resulted in a weak recommendation (grade 2C) [6]. In addition,
sedation protocols are quite variable across institutions and are usually based on individual parameters,
local resources, and operator preferences. Initial studies were done under general anesthesia [5],
but recently, several centers have started using moderate or deep sedation. In fact, studies conducted to
evaluate and compare different sedation levels during EBUS-TBNA have shown conflicting results [7–9].
In this sense, based on the existing literature, a prospective, multicenter study was conducted to
assess patient safety and comfort, EBUS-TBNA diagnostic accuracy, and related complications under
two different protocols: (1) total intravenous general anesthesia with neuromuscular blockade under
controlled ventilation, and (2) intravenous sedation.
2. Experimental Section
2.1. Study Design and Measured Outcomes
This prospective, multicenter study was performed between March and October 2014 in two
pulmonology departments, (1) at the Centro Hospitalar de São João (Porto, Portugal), an academic
tertiary institution, and (2) at the Hospital Beatriz Ângelo (Lisbon, Portugal), a non-tertiary hospital.
It was approved by both hospital ethical committees, and all patients gave written informed consent
before being enrolled in this study.
The study primary outcome was EBUS-TBNA accuracy, determined based on the adequate
number compared to the total number of samples. Cytological samples were validated and
classified by a pathologist as positive (providing a diagnosis of cancer or specific benign disease),
adequate (when lymph nodes presented a suitable cellular component, lymphocytes, and pigmented
macrophages), or inadequate (when cellular components, blood, or bronchial epithelial cells were
absent or there was insufficient material to obtain a definitive diagnosis). In the case a definitive
diagnosis could not be achieved, surgical procedures or clinical and radiological follow-up for at least
12 months were recommended. As study secondary outcomes we considered safety, patient comfort
and satisfaction, and operators’ difficulties. Safety was measured by the EBUS-TBNA rate and
anesthetic-related complications, and by hemodynamic parameter analysis. Comfort was assessed
by a specific questionnaire and by the patient´s willingness to repeat the exam. Bronchoscopist and
anesthesiologist difficulties were recorded by means of a specific questionnaire.
2.2. Patients
All patients referred for EBUS-TBNA, aged over 18 years, and with the capacity to sign the
informed consent form were included in this study. Exclusion criteria included contraindications
for EBUS or tracheal intubation, history of anesthetic drug allergy, pregnancy, need for additional
bronchoscopic procedures, and presence of severe neuropsychiatric conditions that affected the
cognitive ability to answer questionnaires.
2.3. Study Protocol
Patients referred for EBUS-TBNA (Figure 1) were randomly allocated to Group 1 (general
anesthesia with neuromuscular blockade and controlled ventilation) or Group 2 (intravenous sedation).
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Initial clinical assessment included demographic data, comorbidities, smoking habits and
medication. Baseline anxiety status was assessed using the “Hospital Anxiety and Depression Scale”
(HADS-A) [10,11], and a specific EBUS-TBNA self-assessment questionnaire on knowledge, fears,
and expectations was provided.
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Figure 1. Study protocol. IGA, intravenous general anesthesia; NMB, neuromuscular blockade;
IVS, intravenous sedation; EBUS-TBNA, endobronchial ultrasound-guided needle aspiration; HADS-A,
Hospital Anxiety and Depression Scale.
The hemodynamic par meters of the patients (blood pressure, pulse oximetry and heart rate) wer
continu usly monitored. Th e time points of the anest tic proc dure were considered for analysis:
beginning (T1), middle (T2), and end (T3). Procedure duration was measured from the beginning
(T1) unt l the end of the anesthesia (T3). Drugs and doses u ed for sedation were also documented.
All proc dures were performed in an outpatient b sis.
Before discharge, all patients included answered a second question aire on exam tolerance and
general satisfaction, respectively, as es ing the main symptoms (i.e., cough, dyspnea, pain) and the
willingness to repeat EBUS-TBNA. Another specific questionnaire was also given to the bronchoscopists
and anesthesiologists.
2.4. Anesthetic Procedure
Patients as igned into Group 1 were submitted to intravenous general anesthesia (IGA) with
neuromuscular blockade (NMB) under controlled ventilation. EBUS was introduced through an
artificial airway (laryngeal mask, orotracheal tube, or rigid scope). Drug options allowed were
alfentanyl/fentanyl, propofol, idazola , suc inylcholine, rocuronium, and sugammadex.
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Patients assigned into Group 2 were submitted to local oropharynx and larynx anesthesia with
2% lidocaine and intravenous sedation, using a combination of alfentanyl/fentanyl, propofol, and/or
midazolam. EBUS was introduced through a mouthpiece and oxygen was delivered through a face mask.
Patients were kept under spontaneous breathing. Sedation level was monitored with the Ramsey Sedation
Scale (RSS) [12] (Appendix A Table A1), aiming for a sedation level ≥4. Time to recovery was assessed by
the Aldrete score [12], where the patients were discharged after reaching an Aldrete score ≥9.
Midazolam was administered in both groups. All anesthetic procedures were performed by
two experienced anesthesiologists (>10 years practice). A specific questionnaire was also applied to
verify the anesthetic difficulties experienced during induction, maintenance, and recovery, and factors
associated with potential problems or complications.
Regarding hemodynamic parameters, hypotension was defined as a systolic pressure <90 mmHg
at any time of the procedure, while hypertension was defined as an increase (>30%) in mean arterial
blood pressure in relation to baseline values, and hypoxemia as a partial pressure of SpO2 <90% for
more than 30 s at any time in the procedure.
The presence or absence of laryngospasm/bronchospasm was determined by pulmonary
auscultation and if there was need for specific treatment or bronchodilator use.
2.5. EBUS-TBNA Technique
EBUS-TBNA was performed as previously reported [13]. A flexible ultrasound bronchoscope
(BF-UC180F, Olympus, Tokyo, Japan) with an integrated convex transducer (7.5 MHz) and Doppler
mode was used. Images were manipulated using an ultrasound console (EU-ME1, Olympus,
Tokyo, Japan or Prosound Alpha10, Aloka, Tokyo, Japan). Once the target lesion was identified,
transbronchial punctures were done with a 22-gauge needle (NA-201SX-4022, Olympus, Tokyo, Japan).
A minimum of four needle passes were done for each lymph node. Then, aspirated specimens were
expelled into a container with preservative liquid, and a cytobloc was prepared and stained for
subsequent cytological examination. Rapid on-site evaluation was not performed, and cytologists did
not know the type of anesthesia applied during EBUS-TBNA.
EBUS-TBNA was performed by four experienced bronchologists (>4 years practice). Then,
a specific questionnaire was applied, assessing experienced difficulties during examination and/or
factors that eventually contributed to a premature interruption.
2.6. Data and Statistical Analysis
Parameters measured included patient demographics, procedure indication, number of punctured
lymph node stations and aspirations per station, pathology results, procedure time, medication
doses, cardiorespiratory parameters, and complications (>50 mL bronchial bleeding, pneumothorax,
mediastinitis, persistent arrhythmia requiring medication, other life-threatening conditions, death),
and were compared between groups. Power analysis (GPower software, version 3.1.9.3; Dusseldorf,
Germany) was used to establish the effect size for subgroup analysis.
All statistical tests were performed using the Statistical Package for the Social Sciences (SPSS),
version 25.0 (SPSS, Inc., Chicago, IL, USA). Results are presented as mean values and standard deviation
(SD). A Kolmogorov–Smirnov test was used to assess the normality of data. Student’s t-test was used
to determine significant differences among two different samples for normally distributed continuous
variables, and Mann–Whitney test for those non-normally distributed. Chi-squared and Fisher tests
were applied for categorical variables. A p value of <0.05 was considered statistically significant.
3. Results
One-hundred and fifteen patients fulfilled the inclusion criteria, and were allocated to Group 1
(n = 59, 51.3%) and Group 2 (n = 56, 48.7%). Sociodemographic and clinical characteristics are shown
in Table 1. There were no significant differences between groups for gender (p = 0.146), age (p = 0.645),
educational degree (p = 0.495), and EBUS indication. Smokers percentage was statistically higher in
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Group 2 (42.9% vs. 27.1%, p = 0.039). Most patients (70.4%) did not show pathological anxiety on the
HADS-A scale; 18.3% were scored as borderline and 11.3% had psychopathology criteria, but without
significant differences between groups (p = 0.763). Twenty-seven patients (23.5%) used psychiatric
drugs, but there were no differences between groups (p = 0.948).
According to EBUS-TBNA specific questionnaire 1 (Table S1), the overall knowledge and fears about
the exam were similar. In Groups 1 and 2, respectively, 70.7% and 66.1% of patients had never heard
of EBUS (p = 0.596), and the major concern was the expectation of diagnosis, which was independent
of the anesthetic method. A total of 76.3% (Group 1) and 71.4% (Group 2) of patients did not mention
any unpleasant moments or complaints during the procedure. One-hundred and eight patients (93.9%),
regardless of group, reported that they would repeat EBUS-TBNA (p = 0.272). On the other hand, among
patients who referred not to repeat the exam, 5 (71.4%) belonged to Group 1 (Table S1).
Table 1. Baseline patient characteristics.
Total Group 1 Group 2 p Value
Age-years (mean ± SD) 60.1 ± 12.8 60.6 ± 13.1 59.5 ± 12.6 0.645
Gender, n (%) Female 34 (29.6) 21 (35.6) 13 (23.2) 0.146Male 81 (70.4) 38 (64.4) 43 (76.8)
Smoking habits, n (%)
Smoker 40 (34.8) 16 (27.1) 24 (42.9)
0.039Ex-smoker 33 (33.0) 15 (25.4) 18 (32.1)
Non-smoker 42 (42.0) 28 (47.5) 25 (25.0)
Scholarity years, n (%)
<4 31 (27.0) 18 (30.5) 13 (23.2)
0.495
4–9 55 (47.8) 25 (42.4) 30 (53.6)
9–12 15 (13.0) 7 (11.9) 8 (14.3)
>12 14 (12.2) 9 (15.3) 5 (8.9)
HADS-A, n (%)
Psycopathology 13 (11.3) 8 (13.6) 5 (8.9)
0.763Borderline 21 (18.3) 7 (11.9) 14 (25.0)
No psycopathology 81 (70.4) 44 (74.6) 37 (66.1)
Psychotropics, n (%) Yes 27 (23.5) 14 (23.7) 13 (23.2) 0.948No 81 (70.4) 45 (76.3) 43 (76.8)
HADS-A: Hospital Anxiety and Depression Scale.
Regarding anesthetic procedures and hemodynamic parameters, among the three time points
considered (T1, T2, T3), mean systolic and diastolic blood pressures were statistically higher in
Group 1 (Table 2), while no significant differences were found between groups for heart rate and
oxygen saturation.
Table 2. Hemodynamic parameters.
Group 1 Group 2 p Value
Systolic blood pressure (mmHg)
Beginning (T1) 143.5 ± 25.9 129.0 ± 21.8 0.002
Middle (T2) 114.7 ± 21.9 106.4 ± 15.0 0.020
End (T3) 127.0 ± 21.9 108.9 ± 17.0 <0.001
Diastolic blood pressure (mmHg)
Beginning (T1) 79.4 ± 13.9 74.6 ± 12.5 0.056
Middle (T2) 69.0 ± 13.1 62.6 ± 11.0 0.005
End (T3) 74.2 ± 13.2 64.2 ± 11.9 <0.001
Heart rate (beats/min)
Beginning (T1) 76.5 ± 17.4 73.6 ± 14.9 0.344
Middle (T2) 79.7 ± 18.2 75.9 ± 14.7 0.233
End (T3) 79.4 ± 18.4 75.1 ± 12.3 0.150
Partial oxygen pressure (%)
Beginning (T1) 96.3 ± 2.7 95.6 ± 3.5 0.289
Middle (T2) 97.5 ± 6.2 96.5 ± 4.2 0.321
End (T3) 96.8 ± 6.4 96.5 ± 4.2 0.357
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Considering Ramsey sedation scale, in all the patients enrolled a score ≥4 was achieved (Table 3,
Appendix A Table A1). The mean dose used of midazolam was 1.4 mg, being significantly higher in
Group 2 as compared to Group 1 (1.6 ± 0.9 mg vs. 1.2 ± 0.9 mg, p = 0.018). Furthermore, Group 1
required more propofol than Group 2 (389.6 ± 157.1 mg vs. 273.0 ± 151.6 mg, p < 0.001), while the
alfentanyl doses used were similar (p = 0.897) (Table S2).
Table 3. Ramsey sedation scores in the studied groups.
Ramsey Scale Group 1 (n) Group 2 (n)
Ramsey 4 0 50
Ramsey 5 0 6
Ramsey 6 59 0
EBUS-TBNA indications were equally distributed between groups (Table 4). A total
of 203 lesions/lymph node stations were punctured, 108 in Group 1 and 95 in Group 2.
On average, more lymph nodes stations were punctured in Group 1 when compared to Group 2
(1.8 ± 1.0 vs. 1.7 ± 1.0, p = 0.472), with the number of punctures per exam in Group 1 also being higher
(6.9 ± 3.1 vs. 6.0 ± 2.5, p = 0.084), but not reaching statistical significance. Moreover, no punctures
were done in three patients, (two belonging to Group 1 and one to Group 2). Lymph node tissue
was obtained in 109 (97.3%) samples, the aspirated material being inadequate in two cases in Group
1 and one in Group 2 (p = 0.742). This corresponded to a similar diagnostic accuracy: 96.5% (55/57)
in Group 1 and 98.2% (54/55) in Group 2, p = 0.580. Procedure duration was similar in both groups
(49.9 ± 14.3 vs. 47.4 ± 14.5 min, p = 0.348).
Table 4. EBUS-TBNA technical information.
Total Group 1 Group 2 p Value
Indication (%)
Lung cancer staging 38 (33.0) 18 (30.5) 20 (35.7)
0.553Diagnosis 77 (67.0) 41 (69.5) 36 (64.3)
Procedure time (mean ± SD) 48.7 ± 14.4 49.9 ± 14.3 47.4 ± 14.5 0.348
Lymph-node stations sampled (mean ± SD) 1.8 ± 1.0 1.8 ± 1.0 1.7 ± 1.0 0.472
Punctures per exam (mean ± SD) 6.4 ± 2.8 6.9 ± 3.1 6.0 ± 2.5 0.084
Table 5 shows the results obtained for final diagnostic classification. No significant differences
were found between groups (p = 0.299).
Table 5. EBUS-TBNA diagnosis.
Total Group 1 Group 2 p Value
Malignancy n (%) 53 (48.6) 22 (40.0) 31 (57.4)
0.299
Granulomatous disease n (%) 9 (8.2) 6 (10.9) 3 (5.6)
Lymphoproliferative disease n (%) 3 (2.8) 2 (3.6) 1 (1.8)
Reactive lymph node/Negative for malignancy n (%) 44 (40.4) 25 (45.5) 19 (35.2)
TBNA was not performed in three cases: two in Group 1 and one in Group 2.
Minor complications occurred in 11 patients (9.6%), with five belonging to Group 1 and six
to Group 2. No significant differences were stated between groups (p = 0.683). Bronchospasm
or laryngospasm requiring bronchodilators, persistent desaturation, and hypotension occurred,
respectively, in 5 (45.5%), 3 (27.3%), and 3 (27.3%) patients. Mediastinitis, one of the major adverse
events, occurred in a patient belonging to Group 1 (0.9%), 15 days after the procedure. This patient
was sent for restaging due to an increase in the lymph node, but it proved to be the result of Surgicel®
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(Ethicon, Johnson & Johnson Medical, Somerville, NJ, USA), being left in mediastinum after a lobectomy
with lymphadenectomy.
Data obtained after bronchoscopist and anesthesiologist questionnaires were completed are shown
in Table 6. Bronchoscopist did not report EBUS-associated adversities in 67% of the cases, with the
difficulties being mainly related to cough (n = 19, 16.5%) and target lesion location (n = 11, 9.6%).
There were with significant differences between groups (p < 0.001). On the other hand, anesthesiologist
did not report any obstacles to the anesthetic technique in 73.9% of the procedures (p = 0.053).
Table 6. Bronchoscopist and anesthesiologist questionnaire.
Bronchoscopist Questionnaire
Total n (%) Group 1 n (%) Group 2 n (%) p Value
1. In which of the following steps did you feel difficulty?
EBUS introduction 6 (5.2) 0 6 (10.7)
<0.001
Target ultrasound identification/recognition 1 (0.9) 0 1 (1.8)
TBNA 16 (13.9) 2 (3.4) 14 (25.0)
Other 15 (13.0) 4 (6.8) 11 (19.6)
None 77 (67.0) 53 (89.8) 24 (42.9)
2. Which factors contributed to the above difficulties?
Patient’s movement 4 (3.5) 0 4 (7.1)
<0.001
Cough 19 (16.5) 1 (1.7) 18 (32.1)
Anatomic factors related to the target lesions 10 (8.7) 1 (1.7) 9 (16.1)
None 82 (71.3) 57 (96.6) 25 (44.6)
Anesthesiologist Questionnaire
1. In which of the following steps did you feel difficulty?
Induction 4 (3.6) 0 4 (7.4)
<0.001
Maintenance 16 (14.3) 2 (3.4) 14 (25.9)
Recovery 8 (7.1) 6 (10.3) 2 (3.7)
None 84 (75) 50 (86.2) 34 (63.0)
2. Which factors contributed to the above difficulties?
Difficult airway 9 (7.8) 1 (1.7) 8 (14.3)
0.053
Laringospam 16 (13.9) 6 (10.2) 10 (17.9)
Hemodynamic alterations 3 (2.6) 1 (1.7) 2 (3.6)
Others 2 (1.7) 1 (1.7) 1 (1.7)
None 85 (73.9) 50 (84.7) 35 (62.5)
4. Discussion
EBUS-TBNA performed under general anesthesia and neuromuscular blockade, as well as
with moderate sedation, seems to be safe and effective. In fact, one of the major advantages in
performing EBUS-TBNA under general anesthesia and neuromuscular blockade is that optimal
procedure conditions can be guaranteed for bronchoscopist, contributing to better EBUS accuracy
and optimal patient comfort [14]. The disadvantages are mainly related to the need for an artificial
airway, mechanical ventilation and associated complications, longer procedure duration, and, possibly,
higher costs [15]. Nevertheless, none of these statements has been proven. Therefore, sedation has some
advantages over general anesthesia as it avoids use of an artificial airway and controlled ventilation,
with a lower hemodynamic impact and shorter recovery phase [9]. In fact, according to the recent
EBUS-specific and American College of Chest Physicians (ACCP) guidelines, either moderate sedation
or deep sedation are acceptable [6]. In this prospective, multicenter clinical study, moderate sedation
with spontaneous breathing was compared with general anesthesia under controlled ventilation, in two
distinct centers, regardless of the EBUS indications.
Although differences in clinical parameters that could influence patients’ tolerance and
satisfaction, anxiety levels, psychotropic drug use, education level, and concerns and previous
information about the exam were not observed in the studied population, statistically significant
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differences were found in relation to smoking habits. In fact, there were more active smokers in the
sedation group, which might have contributed to the occurrence of cough. This symptom could not be
compared with the patients of Group 1, since they were under neuromuscular blockade.
Patient comfort during the exam is difficult to assess, since all patients were exposed to midazolam.
Thus, to overcome this question, a questionnaire was applied regarding specific moments of the
procedure, instead of more objective symptom quantification. The most frequent complaints were the
waiting period immediately before and during the onset of anesthetic procedure. Patient satisfaction
was assessed by the willingness to repeat EBUS, as was done already in other studies on this
issue [15–17]. Despite being statistically similar in both groups, more patients (n = 5) belonging
to the general anesthesia group refused EBUS repetition than in the sedation group (n = 2).
Patient satisfaction was achieved with both anesthesia techniques, which means that the
examination can be performed under sedation without affecting patient satisfaction. Steinfort et al. [15]
were the first to reflect on patient satisfaction during EBUS, and found that EBUS-TBNA performed
under conscious sedation with midazolam, fentanyl, and/or propofol was associated with higher
patient satisfaction, with 98% answering that they would “definitely” would return to repeat the
exam if necessary. On the other hand, Sarkiss et al. [14] described EBUS under general anesthesia in
more than 200 patients without finding any major complications, but no reference was made to the
diagnostic yield. In this study, EBUS-TBNA accuracy was considered similar in both groups.
Yarmus et al. [7] conducted a retrospective analysis of EBUS performed in two different centers,
with different anesthetic methods: deep sedation with propofol, or moderate sedation with fentanyl
and midazolam, and stated that the number of lymph nodes sampled (2.2 vs. 1.4 per patient, p < 0.001)
and the diagnostic yield under deep sedation were higher (80% vs. 66%, p < 0.001) than in the moderate
sedation group. Oztas et al. [18] retrospectively compared two types of sedation: propofol–midazolam
and midazolam alone, and found no differences in the EBUS-TBNA diagnostic value and complication
rate. Similarly, Casal et al. [8] randomly included 140 patients to undergo the procedure under
general anesthesia or moderate sedation (midazolam plus fentanyl), to determine and compare the
diagnostic yield, complication rate, and patient tolerance between groups. Interestingly, in our study,
although there are some differences in the protocol used for anesthesia, it corroborates its findings.
The mean number of lymph nodes/lesions sampled per patient (1.8 ± 1.0) did not reach statistical
difference between groups, but this value was lower in comparison with those reported in other studies,
and can be explained by the predominance of the diagnostic indication over staging. In fact, EBUS was
performed for lung cancer staging only in 33% of patients. In addition, a shorter procedure time would
be expected in the sedation group. However, while it was somewhat shorter, the difference was not
significant, as found by Postelnicu et al. [19]. Furthermore, Yarmus et al. [7] found a significantly
shorter procedure time in the deep sedation group when compared to the moderate sedation group,
in which more punctures were done per patient. Indeed, procedure time may also be influenced by
other factors, such as the experience of the bronchoscopist or number of punctures, rather than the
type of anesthesia used.
Another important and often neglected issue that should be highlighted as it alters the overall
outcomes is operator preferences and skills, as mentioned by Kang et al. [20]. There were no differences
in the difficulties of the procedure, as assessed by the bronchoscopists, anesthesiologists, and nurses.
Similarly, in both groups, sedation was not deep enough to cause discomfort during the procedure,
clearly indicating that there is no preference for sedation or general anesthesia techniques. EBUS-TBNA
is recognized as being a safe procedure. In the largest published survey, including 7345 EBUS-TBNA
procedures, there were sparse complications, with 14 cases (0.19%) of infectious complications and
seven of mediastinitis [21]. In a multicenter registry (the Quality Improvement Registry, Evaluation
and Education (AQuIRE) survey), among the 1317 patients included, 19 (1.44%; 95% confidence
interval (CI), 0.87–2.24%) had EBUS-TBNA complications and one patient died. As only 24 h of
complications were recorded, some cases of infection could have been lost [22]. In this study, only one
serious complication was reported. Mediastinitis occurred in a patient that had previously undergone
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lymphadenectomy, in which Surgicel® was left, but after surgical and antibiotic treatment, the patient
recovered completely. In the general anesthesia group, a higher mean arterial pressure was found,
probably as a consequence of endotracheal intubation. This raise may represent an increased risk
for cardiovascular events, although none occurred in this study. As expected, the propofol dose was
higher in the general anesthesia group, while the dose of midazolam was higher in the sedation group,
and no major drug-related adverse events were observed.
5. Conclusions
Overall, this study, conducted in two different centers with distinct differentiation levels,
clearly reflects the independence of the operator and center results. Moreover, after considering
the conflicting results from retrospective studies, our results are consistent with those obtained in
other randomly assigned studies. The type of anesthesia did not influence EBUS-TBNA outcomes.
Thus, based on our findings it seems feasible to conclude that EBUS under moderate sedation may be
the first-choice method without compromising diagnostic yield, complication rate, patient comfort,
and satisfaction.
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Appendix A
Table A1. Ramsey sedation scale (RSS).
Score Response
Ramsey 1 Anxious, agitated, restless
Ramsey 2 Cooperative, oriented, tranquil
Ramsey 3 Responsive to commands only
Ramsey 4 Brisk response to light glabellar tap or loud auditory stimulus
Ramsey 5 Sluggish response to light glabellar tap or loud auditory stimulus
Ramsey 6 No response to light glabellar tap or loud auditory stimulus
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